Current status and progress of molecular targeted drug therapy in metastatic renal cell carcinoma
Zhang Fan
Guo Gang
Li Xintao
Chen Luyao
Zhang Xu
Abstract：Renal cell carcinoma is one of the most common urological malignancies.Molecular targeted therapy is the main treatment formetastatic renal cell carcinoma at present.By targeting specificspot and signaling pathways,targeted therapy can inhibit the proliferation of tumor cells and then exert the function of anti-tumor on the basis of differences between tumor tissue and normal tissue in the aspect of molecular biology such as genes,signal transduction.This review mainly summarizes current status and progress of molecular targeted drug therapy in the treatment of metastatic renal cell carcinoma.
Keywords：renal cell carcinomametastasistargeted therapy
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 113-118 )